Adrenal insufficiency screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S [2] Muhammad Saad, M.B.B.S.[3]

Overview

There is insufficient evidence to recommend routine screening for adrenal insufficiency. Newborn screening for congenital adrenal hyperplasia is recommended.

Screening

There is insufficient evidence to recommend routine screening for adrenal insufficiency. ^[1]The most common causes of primary adrenal insufficiency are autoimmune adrenalitis and congenital adrenal hyperplasia due to 21-Hydroxylase deficiency. Screening is recommended in childern suspected of developing congenital adrenal hyperplasia.^[2]

References

↑ Chanson, Philippe; Guignat, Laurence; Goichot, Bernard; Chabre, Olivier; Boustani, Dinane Samara; Reynaud, Rachel; Simon, Dominique; Tabarin, Antoine; Gruson, Damien; Reznik, Yves; Raffin Sanson, Marie-Laure (2017). “Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis”. Annales d’Endocrinologie. 78 (6): 495–511. doi:10.1016/j.ando.2017.10.005. ISSN 0003-4266.
↑ Therrell BL (March 2001). “Newborn screening for congenital adrenal hyperplasia”. Endocrinol Metab Clin North Am. 30 (1): 15–30. doi:10.1016/s0889-8529(08)70017-3. PMID 11344933.

Template:WH Template:WS

[ChansonGuignat2017-1] Chanson, Philippe; Guignat, Laurence; Goichot, Bernard; Chabre, Olivier; Boustani, Dinane Samara; Reynaud, Rachel; Simon, Dominique; Tabarin, Antoine; Gruson, Damien; Reznik, Yves; Raffin Sanson, Marie-Laure (2017). “Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis”. Annales d’Endocrinologie. 78 (6): 495–511. doi:10.1016/j.ando.2017.10.005. ISSN 0003-4266.

[pmid11344933-2] Therrell BL (March 2001). “Newborn screening for congenital adrenal hyperplasia”. Endocrinol Metab Clin North Am. 30 (1): 15–30. doi:10.1016/s0889-8529(08)70017-3. PMID 11344933.

[1]

[2]